This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
4 Outpatient Home Health Stocks in Focus as Market Dynamics Change
by Zacks Equity Research
An aging population and rising AI adoption position the Zacks Medical - Outpatient and Home Healthcare industry for solid growth. EHC, DVA, OPCH and PNTG stand to benefit.
DVAPositive Net Change EHCPositive Net Change PNTGPositive Net Change OPCHPositive Net Change
medical medical-devices
National Vision Stock Surges 154.6% in a Year: What's Driving it?
by Zacks Equity Research
EYE shares jump 154% in a year as America's Best fuels comps, new stores and fleet optimization, showing early gains from strategic execution.
ILMNPositive Net Change PODDNegative Net Change EYENegative Net Change BTSGPositive Net Change
medical medical-devices
3 MedTech Innovators Shaping Healthcare in 2026: AVAH, INGN & CCLD
by Indrajit Bandyopadhyay
AVAH, INGN & CCLD show how home care, portable oxygen tech and cloud healthcare IT are reshaping care delivery and efficiency into 2026.
INGNPositive Net Change AVAHNegative Net Change CCLDNegative Net Change
medical medical-devices
Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica
by Zacks Equity Research
RVTY unveils Signals Xynthetica, an AI-augmented design platform that links predictive models with real lab data to speed discovery.
MEDPPositive Net Change KRMDPositive Net Change CCLDNegative Net Change RVTYPositive Net Change
medical medical-devices
ECL Boosts High-Tech Water Platform With Ovivo's Electronics Business
by Zacks Equity Research
Ecolab closes Ovivo Electronics acquisition, expanding high-tech water solutions for semiconductors and boosting circular water offerings.
BSXPositive Net Change ECLPositive Net Change ISRGNegative Net Change MEDPPositive Net Change
medical medical-devices
Top China Tech Plays in US Markets Amid Trade Deal Progress
by Vasundhara Sawalka
Chinese technology stocks in U.S. markets are rebounding as trade deal progress lifts sentiment and major advances in chips, EVs and AI boost confidence.
NTESNegative Net Change TCEHYPositive Net Change BILIPositive Net Change PDDPositive Net Change
artificial-intelligence china e-commerce electric-vehicles medical-devices robotics tech-stocks
3 Skyrocketing MedTech Stocks That Might Lose Steam in 2026
by Zacks Equity Research
Here are some surging MedTech stocks - GMED, TMDX and HIMS - that may face slowing momentum in 2026.
GMEDPositive Net Change TMDXNegative Net Change HIMSNegative Net Change
medical medical-devices
Here's Why You Should Hold DaVita Stock in Your Portfolio for Now
by Zacks Equity Research
DVA stock gets support from a patient-centric model, Q3 revenue growth and overseas expansion, even as reliance on commercial payers remains a risk.
BSXPositive Net Change ISRGNegative Net Change DVAPositive Net Change MEDPPositive Net Change
medical medical-devices
Should You Continue to Hold CRL Stock in Your Portfolio for Now?
by Zacks Equity Research
Charles River gains from strong RMS demand, strategic partnerships and solid finances but faces macro and competitive pressures in 2025.
ILMNPositive Net Change CRLPositive Net Change PODDNegative Net Change BTSGPositive Net Change
medical medical-devices
Will Direct Distribution in Southern Europe Boost ISRG's Margins?
by Indrajit Bandyopadhyay
ISRG plans a 2026 shift to direct distribution in Italy, Spain, and Portugal, aiming to lift margins by capturing distributor economics with execution risk.
SYKPositive Net Change ISRGNegative Net Change ZBHNegative Net Change
medical medical-devices
Here's Why You Should Retain CLOV Stock in Your Portfolio Now
by Zacks Equity Research
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
MEDPPositive Net Change KRMDPositive Net Change CLOVNegative Net Change CCLDNegative Net Change
medical medical-devices
Boston Scientific's Global Expansion: What's Behind the Growth?
by Moumi Mondal
BSX expands globally with R&D, AI-driven manufacturing and Emerging Markets, aiming for $1B+ revenues in China in 2025.
BSXPositive Net Change MDTPositive Net Change ISRGNegative Net Change
medical medical-devices
GEHC Expands Healthcare Access Through Indonesia MoH Partnership Deal
by Zacks Equity Research
GE HealthCare partners with Indonesia's Health Ministry under SIHREN to deploy CT scanners nationwide, expanding diagnostics across public hospitals.
BSXPositive Net Change ISRGNegative Net Change MEDPPositive Net Change GEHCPositive Net Change
medical medical-devices
HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases
by Zacks Equity Research
Hologic shares dip as the company unveils new study data showing its Genius AI mammography flags 32% of previously missed breast cancer cases.
ISRGNegative Net Change HOLXPositive Net Change VCYTPositive Net Change AORTPositive Net Change
genetic-testing immuno-therapy medical medical-devices
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
by Zacks Equity Research
DXCM's strong Q3 growth, expanding CGM coverage and innovation-driven momentum position it for sustained adoption despite rising competition.
BSXPositive Net Change ISRGNegative Net Change DXCMPositive Net Change MEDPPositive Net Change
medical medical-devices
Tempus AI Turns Non-GAAP Profit on Surging Genomics and Data
by Urmimala Biswas
Tempus AI posts first positive adjusted EBITDA as genomics testing accelerates and data bookings broaden. Zacks Rank #3 (Hold) with mixed Style Scores.
TXGPositive Net Change DOCSNegative Net Change TEMNegative Net Change
artificial-intelligence consensus-outlook earnings earnings-consensus medical medical-devices
Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers
by Moumi Mondal
HOLX's Genius AI Detection flags missed breast cancers, showing promise in improving mammography accuracy and radiologist efficiency.
BDXPositive Net Change HOLXPositive Net Change GEHCPositive Net Change
medical medical-devices
Hims & Hers Scales Technology-Driven Care as Profitability Evolves
by Debanjana Dey
HIMS scales personalized care, expands globally and invests in technology as it balances growth with evolving profitability.
GDRXNegative Net Change HIMSNegative Net Change TEMNegative Net Change
medical medical-devices
BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe
by Zacks Equity Research
BDX expands its BD MAX menu in Europe with IVDR-approved respiratory and STI assays, boosting system utility and reinforcing its diagnostics growth strategy.
BDXPositive Net Change CAHNegative Net Change COOPositive Net Change BTSGPositive Net Change
immuno-therapy medical medical-devices
The Longevity Shift: Healthcare REITs to Benefit From Global Aging
by Urmimala Biswas
WELL, VTR, CTRE and OHI are tapping the longevity economy as aging populations drive rising demand for senior housing, skilled nursing and long-term care real estate.
VTRNegative Net Change OHINegative Net Change CTRENegative Net Change WELLNegative Net Change
finance healthcare medical medical-devices
Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up
by Urmimala Biswas
Tempus AI's Q3 revenue surged as oncology and hereditary testing led the way, margins improved, and pricing tailwinds and regulatory milestones took shape.
TXGPositive Net Change DOCSNegative Net Change TEMNegative Net Change
artificial-intelligence earnings-growth earnings-outlook healthcare medical medical-devices
3 MedTech Stocks Poised to Gain in 2026 From the AI Boom
by Sridatri Sarkar
AI is reshaping MedTech, and Stryker, Tempus AI and GE HealthCare are emerging as key players leveraging AI across surgery, diagnostics and imaging.
SYKPositive Net Change NVDAPositive Net Change GEHCPositive Net Change TEMNegative Net Change
artificial-intelligence medical medical-devices
Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now?
by Zacks Equity Research
PAHC rides on strong Animal Health momentum, vaccine growth and emerging market demand, even as macro and competitive risks linger.
ILMNPositive Net Change PODDNegative Net Change PAHCPositive Net Change BTSGPositive Net Change
medical medical-devices
TMO Stock Set to Gain From the Expansion of Gibco Bacto Portfolio
by Zacks Equity Research
Thermo Fisher expands its Gibco Bacto CD portfolio with new formulations aimed at boosting E. coli-based plasmid DNA and protein production efficiency.
TMOPositive Net Change ILMNPositive Net Change PODDNegative Net Change BTSGPositive Net Change
medical medical-devices
Tempus AI Near $75 Target? Valuation, Upside and Risks
by Urmimala Biswas
Tempus AI's rally meets a $75 target. Here's how valuation, catalysts, risks, and key numbers set up the risk-reward into 2026.
TXGPositive Net Change DOCSNegative Net Change TEMNegative Net Change
artificial-intelligence healthcare medical medical-devices